SAN DIEGO, March 23rd, 2024 — In a groundbreaking announcement today, PrecisePK, a global leader in therapeutic drug monitoring software, proudly unveils a transformative partnership with four prominent hospitals across Oahu and Kauai. Kapi’olani Medical Center, Straub Medical Center, Pali Momi Medical Center, and Wilcox Medical Center have joined forces with PrecisePK in a strategic collaboration set to redefine delivery of precision medicine in the Hawaiian islands.
This pioneering collaboration demonstrates a dedicated effort to propel patient care, streamline operations, and foster technological advancement within the healthcare domain. By joining forces, these esteemed healthcare institutions aim to utilize PrecisePK and its state-of-the-art solutions to bolster personalized dosing capabilities, including adhering to the vancomycin AUC dosing guideline. Through meticulous consideration of patient and drug variables, they will employ Bayesian-derived, model-informed precision dosing techniques, thus optimizing treatment outcomes.
Kapi’olani Medical Center, a leader in pediatric and neonatal care, with its expansive 150-160 adult bed capacity, is set to benefit from PrecisePK's innovative solutions. The collaboration aims to strengthen pediatric and NICU services. This collaboration represents a concerted effort to fortify the hospital's standing as a premier teaching facility, actively engaged in advancing medical education and community health outreach initiatives.
Straub Medical Center, as the largest of the four hospitals has received numerous national awards recognizing its excellence in patient experience, patient safety. It is a fully integrated not-for-profit medical center with a 159-bed hospital in Honolulu, a network of neighborhood clinics and a visiting specialist program that reaches throughout the state of Hawaii.PrecisePK will work collaboratively to enhance adult care and specialized treatment areas.
Pali Momi Medical Center, with approximately 140 beds, is known for its full range of high quaity services. It has delivered many medical firsts for the community. It will optimize operations and patient experiences with PrecisePK's solutions, contributing to the elevation of healthcare standards.
Wilcox Medical Center is another vital healthcare hub in Kauai. Over the years, Wilcox Medical Center has introduced many innovative services to the Kauai community. In 1968, Wilcox pharmacist Betty Bell introduced an innovative unit dose system of distribution, improving the safer and more efficient delivery of patient medication. Today, the collaboration with PrecisePK aims to further strengthen Wilcox's capabilities in medicine dosing management.
This strategic alignment represents PrecisePK's commitment to driving innovation in healthcare and facilitating partnerships that enhance patient outcomes. As healthcare landscapes evolve, PrecisePK remains dedicated to empowering healthcare institutions with state-of-the-art solutions that optimize treatments and promote overall well-being.
About PrecisePK
PrecisePK is a leading global provider of therapeutic drug monitoring software for Bayesian model-informed precision dosing (MIPD). By leveraging real-time bedside assistance in drug dosing, therapeutic analytics, local populations model, AKI predictor, and other resources, the software is designed to streamline the work necessary to achieve individualized treatment and safeguard patient care, at the point of care. In addition to its robust vancomycin AUC calculator, PrecisePK offers a wide array of drug modules that aid in the workflow of infectious diseases and several other therapeutic areas including neurology, oncology, cardiology, and pulmonology. Visit PrecisePK's website for a free trial.
